Clinical Effects of Hyperthermia on Colorectal Cancer Chemotherapy Patients

42.3 KB of clinical trial data exploring the effects of deep hyperthermia on chemotherapy side effects, inflammation, immune function, and quality of life in patients undergoing adjuvant chemotherapy after colorectal cancer surgery. The dataset, authored by Lei Zhao and last updated in May 2026, contains results showing statistically significant differences in adverse events and biomarker levels between experimental and control groups.

Use Cases

• Analyzing the impact of hyperthermia on chemotherapy-induced bone marrow suppression based on reported incidences of neutropenia and thrombocytopenia.
• Modeling the relationship between hyperthermia and inflammation biomarkers based on measured levels of PCT and IL-6.
• Evaluating hyperthermia's effect on patient-reported outcomes based on pre- and post-chemotherapy GIQLI scores.
• Comparing liver function outcomes between treatment groups based on reported incidences of hyperbilirubinemia and ALT elevation.

Strengths

• Data includes multiple clinical outcome measures: adverse events (nausea, vomiting, liver damage), immune biomarkers (PCT, IL-6, C3, C4, C1q), and quality of life scores (GIQLI).
• Results are reported with statistical significance (P < 0.05) for key comparisons between experimental and control groups.
• Dataset is openly licensed under CC-BY-4.0, facilitating reuse and analysis.

Limitations

• Row count is unknown, which may limit suitability assessment for statistical modeling.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 42.3 KB, indicating a limited scope or sample size.

Provenance

Source

figshare, author Lei Zhao.

Collection Method

Likely collected from a clinical trial or observational study, as described.

Time Range

null

Freshness

Last updated 2026-05-08 14:26:39; freshness should be verified.

Geography

null